Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051214901> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2051214901 abstract "Since the discovery of p53 as guardian of the genome, a large number of efforts have been put in place in order to find molecular strategies aiming to restore p53 wild-type functions, particularly in the light of the fact that its pathway results ineffective in most tumors even though they have non-mutated p53. In this context, pediatric cancers, that are mostly p53 wild-type at the time of diagnosis, represent an ideal target for such therapeutic approach. Within the several mechanisms and proteins ruling p53 activity, the murine double minute 2 (MDM2) is its crucial negative regulator, frequently found overexpressed in p53-wild-type tumors. The development of new technologies such as nuclear magnetic resonance structure analyses, computational structure-based design studies, and library peptides screening have recently led to the discovery and characterization of a large number of compounds belonging to different chemical families that are able to target the interaction p53-MDM2, rescuing the p53 wild-type pathway with an overall pro-apoptotic and anticancer activity. Within the preclinical assessment of these molecules, the cis-imidazoline analogue Nutlin-3 has definitely attracted great interest for its in vitro and in vivo antitumor activity in several pediatric cancer models, either as single agent on in combination with standard chemotherapy. In this light, the aim of this review is to summarize the main preclinical evidences of the potential of MDM2 inhibitors for the treatment of childhood cancers and the key suggestions coming from their assessment in the treatment of adult cancers as proof of concept for future pediatric clinical studies." @default.
- W2051214901 created "2016-06-24" @default.
- W2051214901 creator A5007867100 @default.
- W2051214901 creator A5041460743 @default.
- W2051214901 creator A5060920053 @default.
- W2051214901 creator A5070154879 @default.
- W2051214901 creator A5075079041 @default.
- W2051214901 creator A5082312639 @default.
- W2051214901 date "2013-04-01" @default.
- W2051214901 modified "2023-09-27" @default.
- W2051214901 title "MDM2 Non-Genotoxic Inhibitors as Innovative Therapeutic Approaches for the Treatment of Pediatric Malignancies" @default.
- W2051214901 doi "https://doi.org/10.2174/0929867311320170007" @default.
- W2051214901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23458617" @default.
- W2051214901 hasPublicationYear "2013" @default.
- W2051214901 type Work @default.
- W2051214901 sameAs 2051214901 @default.
- W2051214901 citedByCount "4" @default.
- W2051214901 countsByYear W20512149012013 @default.
- W2051214901 countsByYear W20512149012014 @default.
- W2051214901 crossrefType "journal-article" @default.
- W2051214901 hasAuthorship W2051214901A5007867100 @default.
- W2051214901 hasAuthorship W2051214901A5041460743 @default.
- W2051214901 hasAuthorship W2051214901A5060920053 @default.
- W2051214901 hasAuthorship W2051214901A5070154879 @default.
- W2051214901 hasAuthorship W2051214901A5075079041 @default.
- W2051214901 hasAuthorship W2051214901A5082312639 @default.
- W2051214901 hasConcept C121608353 @default.
- W2051214901 hasConcept C126322002 @default.
- W2051214901 hasConcept C151730666 @default.
- W2051214901 hasConcept C190283241 @default.
- W2051214901 hasConcept C207001950 @default.
- W2051214901 hasConcept C2776192174 @default.
- W2051214901 hasConcept C2779343474 @default.
- W2051214901 hasConcept C2993561819 @default.
- W2051214901 hasConcept C502942594 @default.
- W2051214901 hasConcept C54355233 @default.
- W2051214901 hasConcept C60644358 @default.
- W2051214901 hasConcept C70721500 @default.
- W2051214901 hasConcept C71924100 @default.
- W2051214901 hasConcept C86803240 @default.
- W2051214901 hasConceptScore W2051214901C121608353 @default.
- W2051214901 hasConceptScore W2051214901C126322002 @default.
- W2051214901 hasConceptScore W2051214901C151730666 @default.
- W2051214901 hasConceptScore W2051214901C190283241 @default.
- W2051214901 hasConceptScore W2051214901C207001950 @default.
- W2051214901 hasConceptScore W2051214901C2776192174 @default.
- W2051214901 hasConceptScore W2051214901C2779343474 @default.
- W2051214901 hasConceptScore W2051214901C2993561819 @default.
- W2051214901 hasConceptScore W2051214901C502942594 @default.
- W2051214901 hasConceptScore W2051214901C54355233 @default.
- W2051214901 hasConceptScore W2051214901C60644358 @default.
- W2051214901 hasConceptScore W2051214901C70721500 @default.
- W2051214901 hasConceptScore W2051214901C71924100 @default.
- W2051214901 hasConceptScore W2051214901C86803240 @default.
- W2051214901 hasLocation W20512149011 @default.
- W2051214901 hasLocation W20512149012 @default.
- W2051214901 hasOpenAccess W2051214901 @default.
- W2051214901 hasPrimaryLocation W20512149011 @default.
- W2051214901 hasRelatedWork W134131299 @default.
- W2051214901 hasRelatedWork W1995216550 @default.
- W2051214901 hasRelatedWork W2016187353 @default.
- W2051214901 hasRelatedWork W2043979785 @default.
- W2051214901 hasRelatedWork W2046407249 @default.
- W2051214901 hasRelatedWork W2059777480 @default.
- W2051214901 hasRelatedWork W2066511043 @default.
- W2051214901 hasRelatedWork W2077914759 @default.
- W2051214901 hasRelatedWork W2091639396 @default.
- W2051214901 hasRelatedWork W2132893182 @default.
- W2051214901 hasRelatedWork W2145282879 @default.
- W2051214901 hasRelatedWork W2147530734 @default.
- W2051214901 hasRelatedWork W2337213724 @default.
- W2051214901 hasRelatedWork W2552699553 @default.
- W2051214901 hasRelatedWork W25654050 @default.
- W2051214901 hasRelatedWork W2690796686 @default.
- W2051214901 hasRelatedWork W2884688463 @default.
- W2051214901 hasRelatedWork W2913150539 @default.
- W2051214901 hasRelatedWork W2925921690 @default.
- W2051214901 hasRelatedWork W3164951170 @default.
- W2051214901 isParatext "false" @default.
- W2051214901 isRetracted "false" @default.
- W2051214901 magId "2051214901" @default.
- W2051214901 workType "article" @default.